AI summary · may contain errors
A quasi-experimental social media campaign in Bauchi state, Nigeria increased HPV vaccination among girls ages 9–14 from 69% baseline to 86% endline over ~3 months.
- Open access
Moving in medRxiv, JNCI: Journal of the National Cancer Institute, The Lancet Global Health, Clinical Cancer Research, The Lancet Infectious Diseases, bioRxiv, Clinical Infectious Diseases and Frontiers in Genetics.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
A quasi-experimental social media campaign in Bauchi state, Nigeria increased HPV vaccination among girls ages 9–14 from 69% baseline to 86% endline over ~3 months.
AI summary · may contain errors
High-risk HPV DNA was detected in 31.4% of 191 women living with HIV attending Connaught Teaching Hospital in Freetown, with HPV 52 most common and only 30% carrying 16/18.
AI summary · may contain errors
HPV-DeepSeek, a whole-genome HPV liquid biopsy, detects HPV+ cancers with 99% sensitivity and specificity and classifies viral physical state from plasma at diagnosis.
AI summary · may contain errors
In a phase 3 trial in Chinese women aged 18–45, the E. coli-produced 9vHPV vaccine showed non-inferior neutralizing antibody responses versus 2vHPV, with GMC ratios of 0·60 (HPV 16) and 0·64 (HPV 18) at month 7.
AI summary · may contain errors
Lactobacillus crispatus–enriched vaginal microbiota in cynomolgus macaques did not reduce Chlamydia trachomatis susceptibility, but it was linked to higher serum anti-CT IgG and a controlled systemic cytokine response after infection.
AI summary · may contain errors
A glmBoost-derived 13-gene transcriptomic panel discriminates cervical neoplastic spectrum with aggregated out-of-fold AUC 0.9161 (95% CI 0.8731–0.9591) across six GEO microarray cohorts.
AI summary · may contain errors
A sequential microbiome therapy (SMT) framework is proposed to restore cervicovaginal ecological balance in hrHPV-associated dysbiosis by combining antimicrobial reset and Lactobacillus stabilization.
AI summary · may contain errors
E2 from papillomaviruses activates an ATM-high, ATR-low DNA damage response by displacing CIP2A from TOPBP1, linked to CIP2A-mediated PP2A inhibition and ATM activation.
AI summary · may contain errors
A one-time HPV catch-up vaccination campaign targeting females aged 9-30 in 132 LMICs could prevent nearly 7 million cervical cancer cases and over 3.5 million deaths, with cost-effectiveness varying by country.
AI summary · may contain errors
In 2022, global cervical cancer screening coverage for women aged 30–49 years using any method was 35% (30–39) over the previous 5 years, with 38% ever screened.
AI summary · may contain errors
No single viral, host, or molecular biomarker has yet shown sufficient accuracy to reliably identify human papillomavirus (HPV) infections linked to persistence or progression.
AI summary · may contain errors
Type-specific HPV antibody binding concentrations are associated with vaccine efficacy against incident infection, persistent infection, and CIN2+ across HPV types, with p < 0.0005 for all outcomes.
AI summary · may contain errors
CombinedNet directionality-aware transcriptomic scoring in 304 TCGA-CESC tumors recovers promoter-minus-inhibitor balance (mean rho = 0.944) and predicts with AUC = 0.780.
AI summary · may contain errors
Integrated multi-omics of 112 Chinese cervical cancer tumor–normal pairs identifies PIK3CA, EP300, and MPRIP as key driver events shaping mutations, copy-number changes, and pathway activity.
AI summary · may contain errors
CROWN, a DINOv2-based self-supervised visual foundation model, achieves over 95% accuracy in 48 patch-level classification evaluations and 98% in 22.
AI summary · may contain errors
A selective PAP plus universal HepB-BD policy in South Africa is modeled as the most cost-effective option, averting the greatest disease burden at a willingness-to-pay threshold of ZAR 57,281.
AI summary · may contain errors
Higher baseline natural killer (NK) and myeloid gene signature expression is associated with improved clinical outcomes in patients with recurrent or metastatic cervical cancer treated with tisotumab vedotin.
AI summary · may contain errors
In 100 p16-positive, HPV DNA-positive oropharyngeal squamous cell carcinomas, strictly episomal HPV16_A1 tumors showed 0 progression events versus 23.1% cumulative incidence at 60 months with integration and/or viral SV.
Journals this month
Topics moving, week to 17 Nov 2026
By field